| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.23 | 5e-06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |